Evidence map›Paper›PMID 33117359›Full record

ReviewFrontiers in immunology2020

Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19.

M Mrityunjaya, V Pavithra, R Neelam, P Janhavi, P M Halami, P V Ravindra

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 2 pooled it
30.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 2 syntheses or guidelines pooled it, 322 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M MrityunjayaDepartment of Biochemistry, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
V PavithraDepartment of Biochemistry, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
R NeelamDepartment of Biochemistry, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
P JanhaviDepartment of Biochemistry, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
P M HalamiDepartment of Microbiology and Fermentation Technology, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
P V RavindraDepartment of Biochemistry, Council of Scientific and Industrial Research-Central Food Technological Research Institute, Mysuru, India.
Central Food Technological Research Institute · INAcademy of Scientific and Innovative Research · INCouncil of Scientific and Industrial Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 is an acute and contagious disease characterized by pneumonia and ARDS. The disease is caused by SARS-CoV-2, which belongs to the family of

Indexed as

Anti-Inflammatory AgentsAntioxidantsAntiviral AgentsBetacoronavirusCoronavirus InfectionsCOVID-19Cytokine Release SyndromeCytokinesDietary SupplementsDrug RepositioningHumansInflammationOxidative StressPandemicsPhytochemicalsPneumonia, ViralAnti-Inflammatory AgentsAntioxidantsAntiviral AgentsCytokinesPhytochemicalsanti-inflammationantioxidantCOVID-19food supplementsimmune-boostingpathogenesisSARS-CoV-2

Identifiers

PMID33117359
PMCPMC7575721
OpenAlexW3092326884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.